Position in BMRN
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$2,204,114
+$28,120 QoQ
Shares Held
38,520
0.0% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#213
of 564 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Erste Asset Management GmbH holds $553,204,959 across 68 Biotechnology names. BMRN ranks #37 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,154,900 | $79,968,339 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
110,210 | $59,177,259 | |
| 3 | SRPT |
Sarepta Therapeutics, Inc.
|
2,568,945 | $46,163,941 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
76,558 | $38,028,654 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
834,000 | $29,515,260 | |
| 6 | DNA |
Ginkgo Bioworks Holdings, Inc.
|
2,536,939 | $25,141,065 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,716 | $24,140,974 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
205,000 | $23,999,350 |
All Filings in BMRN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,204,114 | 38,520 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $2,175,994 | 38,520 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,289,243 | 38,520 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,086,243 | 38,520 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,682,316 | 48,796 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,583,134 | 50,688 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,501,014 | 69,935 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $48,495,531 | 689,935 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $57,147,311 | 694,125 | Shares | Sole | 2024-11-26 | |
| 2024-03-31 | $53,637,677 | 614,125 | Shares | Sole | 2024-11-26 | |
| 2023-12-31 | $61,142,332 | 634,125 | Shares | Sole | 2024-11-26 | |
| 2023-09-30 | $53,806,900 | 608,125 | Shares | Sole | 2024-11-26 | |
| 2023-06-30 | $51,105,834 | 589,592 | Shares | Sole | 2024-11-26 | |
| 2023-03-31 | $57,298,086 | 589,244 | Shares | Sole | 2024-11-26 | |
| 2022-12-31 | $53,216,006 | 514,214 | Shares | Sole | 2024-11-26 | |
| 2022-09-30 | $43,676,386 | 515,234 | Shares | Sole | 2024-11-26 | |
| 2022-06-30 | $42,368,944 | 511,270 | Shares | Sole | 2024-11-26 | |
| 2022-03-31 | $43,303,215 | 561,650 | Shares | Sole | 2024-11-25 | |
| 2021-12-31 | $53,743,305 | 608,300 | Shares | Sole | 2024-11-25 | |
| 2021-09-30 | $47,015,507 | 608,300 | Shares | Sole | 2024-11-25 | |
| 2021-06-30 | $50,472,856 | 604,900 | Shares | Sole | 2024-11-25 | |
| 2021-03-31 | $45,675,999 | 604,900 | Shares | Sole | 2024-11-25 | |
| 2020-12-31 | $46,786,121 | 533,540 | Shares | Sole | 2024-11-25 | |
| 2020-09-30 | $35,205,259 | 462,740 | Shares | Sole | 2024-11-25 | |
| 2020-06-30 | $46,602,785 | 377,840 | Shares | Sole | 2024-11-22 | |
| 2020-03-31 | $27,732,900 | 328,200 | Shares | Sole | 2024-11-22 | |
| No filing history on record for this holder in this stock. | ||||||